MicroRNA‐122 and cytokeratin‐18 have potential as a biomarkers of drug‐induced liver injury in European and African patients on treatment for mycobacterial infection

Pharmacokinetics, SAfety/tolerability, and EFficacy of high-dose RIFampicin in tuberculosis-HIV co-infected patients on efavirenz- or dolutegravir-based antiretroviral therapy: study protocol for an open-label, phase II clinical trial (SAEFRIF)

(2020) Ruth Nabisere et al.   Trials

Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort

(2018) Rachel J. Church et al.   HEPATOLOGY

British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)

(2017) Charles S Haworth et al.   THORAX

Mechanism of isoniazid-induced hepatotoxicity: then and now

(2016) Imir Metushi et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

How to treat paracetamol overdose and when to do it

(2016) Daniel J Antoine et al.   Expert Review of Clinical Pharmacology

Hepatotoxicity mechanisms of isoniazid: A mini-review

(2015) Hozeifa M. Hassan et al.   JOURNAL OF APPLIED TOXICOLOGY

miRNA Stability in Frozen Plasma Samples

(2015) Francesca Balzano et al.   MOLECULES

Analysis of Biobanked Serum from a Mycobacterium avium subsp paratuberculosis Bovine Infection Model Confirms the Remarkable Stability of Circulating miRNA Profiles and Defines a Bovine Serum miRNA Repertoire

(2015) Ronan G. Shaughnessy et al.   PLoS One

Comprehensive microRNA profiling in acetaminophen toxicity identifies novel circulating biomarkers for human liver and kidney injury

(2015) A. D. B. Vliegenthart et al.   Scientific Reports

Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital

(2013) Daniel J. Antoine et al.   HEPATOLOGY

Alanine Aminotransferase: A Clinical and Regulatory Tool for Detecting Liver Injury–Past, Present, and Future

(2012) J R Senior   CLINICAL PHARMACOLOGY & THERAPEUTICS

Mechanistic biomarkers in acute liver injury: Are we there yet?

(2012) Danielle Adebayo et al.   JOURNAL OF HEPATOLOGY

Case Definition and Phenotype Standardization in Drug-Induced Liver Injury

(2011) G P Aithal et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments

(2009) S. A. Bustin et al.   CLINICAL CHEMISTRY

Circulating microRNAs, potential biomarkers for drug-induced liver injury

(2009) K. Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Muscular exercise can cause highly pathological liver function tests in healthy men

(2007) Jonas Pettersson et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Antituberculosis drug-induced hepatotoxicity: Concise up-to-date review

(2007) Alma Tostmann et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY